Penny Stocks and Under-Cap Stocks Heading to Watchlist One After Another… Is the '100 Delistings' Becoming a Reality?

조선일보

Lean Right

Factuality

Ownership

Domestic pharmaceutical and biotech companies have been designated as "management stocks" by the Korea Exchange. Going forward, if they fail to escape the status of "penny stocks" trading below 1,000 won, they could face delisting. To weather this crisis, companies have begun seeking breakthroughs to boost stock prices and appease retail investors. ◇ Stock Consolidation Amid Concerns Over Penny Stock Delisting According to the Korea Exchange on …

연합뉴스-Yonhap News Agency

Lean Right

Factuality

Ownership

(Seoul = Yonhap News) Reporter Hwang Cheol-hwan = Since the implementation of measures to strengthen delisting requirements for the removal of failing companies, 'penny stocks' with a share price below 1,000 won or 'stocks failing to meet market capitalization criteria...